普洛药业：CDMO业务现已是公司毛利最高的板块，并已成为公司业绩增长的主要引擎

Group 1 - The company acknowledges that its stock price is influenced by various factors including macroeconomic environment, policy landscape, industry cycles, and operational performance [1] - The company emphasizes its commitment to value creation and sharing, highlighting its strategic transformation and enhancement of core competitiveness [1] - The CDMO business segment is noted as the highest gross margin area and a key driver of the company's performance growth [1] Group 2 - The company is focused on enhancing shareholder returns through cash dividends and share buybacks [1] - The management expresses gratitude for investor attention and aims to ensure that investors share in the company's development achievements [1]